CClinicalTrials.gg
Status unknownNCT01417572Updated Aug 16, 2011

Adjunctive Local Application of Lidocaine During Scleral Buckling Under General Anesthesia

A Phase 4 interventional study of lidocaine in Retinal Detachment, sponsored by Isfahan University of Medical Sciences. Status unknown at 1 site in Iran, Islamic Republic of. Open to participants aged 20 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-08-16.

Sponsored by Isfahan University of Medical Sciences · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2010), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effect of topical lidocaine in scleral buckling surgery.

02

Conditions studied

  • Retinal Detachment

Browse trials for

03

In context

Retinal Detachment

207 studies on the registry are indexed under Retinal Detachment; 27 are open to participants now.

This study's planned enrollment of 30 is below the median of 50 across 136 interventional studies indexed under Retinal Detachment.

Browse Retinal Detachment studies →

Lead sponsor

Isfahan University of Medical Sciences is the lead sponsor of 145 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Retinal detachment
  • Retinal tear less than 3 hour clock

Exclusion criteria

Exclusion Criteria:

  • Vitreous hemorrhage
  • Proliferative vitreoretinopathy
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    lidocaine

    Drug: lidocaine

Interventions

  • Druglidocaine

    to evaluate the effect of lidocaine on oculocardiac reflex during the surgery

06

What researchers measure

Primary outcomes

  1. intraoperative heart rate measurement

    Time frame: 6 month

  2. decrease in pain and nausea,vomiting after surgery

    Time frame: 6 month

  3. decrease in ocr after application of topical lidocaine

    Time frame: 6 month

  4. postoperative nausea and vommitting

    Time frame: 6 month

  5. postoperative pain

    Time frame: 6 month

07

Study locations

1 of 1 sites recruiting
  • Isfahan University of Medical Sciences
    Isfahan, 7864329800, Iran, Islamic Republic of
    • amin masjedi, MD · Contact · Masjedi1827@gmail.com · +983112211915
    • Amin Masjedi, MD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 16, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01417572
Lead sponsor
Isfahan University of Medical Sciences
First posted
Aug 16, 2011
Start date
Jan 2010
Primary completion
Aug 2010
Completion
Sep 2011 (estimated)
Last update
Aug 16, 2011

Study contacts

Amin Masjedi, MD
Contact
Masjedi1827@gmail.com
+983112211915
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion